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Abstract
Autophagy is a highly conserved lysosomal degradation pathway, which has been
shown to play a pivotal role during normal physiological and pathological conditions.
Many proteins and signaling pathways have been shown to regulate autophagy during
different  stages  of  the  process.  Modifying  autophagy-related  proteins  (Atg)  by
posttranslational modification (PTM) is an important way to control proper autophagic
activity. Ubiquitination is one of the PTM that has a crucial role in controlling protein
stability and functions. Proteins can be conjugated with ubiquitin chains with different
topologies that are associated with different outcomes. Many autophagy regulators are
found to be substrates for ubiquitin E3 ligases or deubiquitinating enzymes (DUBs).
Ubiquitination  modifications  of  these  autophagy  regulators  result  in  autophagy
induction or termination. Moreover, ubiquitin is also involved in selective autophagy
by acting as a degradation signal. Here, we are going to review how E3 ligases and
DUBs  function  in  autophagy  regulation  and  discuss  the  recent  findings  about
ubiquitination regulation in autophagy-related processes and diseases.
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1. Introduction
Proteome dynamics and complexity are tightly regulated to maintain normal cellular function
and homeostasis. The ubiquitin-proteasome system (UPS) and autophagy are the two main
intracellular  degradative machineries  in  eukaryotes  [1,  2].  UPS mainly degrades  specific
short-lived proteins, whereas autophagy is responsible for the bulk degradation of long-lived
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proteins and damaged organelles. Autophagy is a lysosome-mediated catabolic process by
which cytoplasmic components are degraded and recycled for cellular homeostasis [3, 4]. It
is  tightly  controlled  by  complex  signaling  pathways  and  serves  as  a  cytoprotective
mechanism in  response  to  environmental  stresses  such  as  nutrient  deprivation,  reactive
oxygen species (ROS), and pathogen invasion [5]. Dysregulation of autophagy pathway has
been implicated in various human diseases [6, 7], including myopathies, aging, neurodegen-
eration, and cancer, as well as in heart, liver, and kidney diseases. To date, more than 35
autophagy-related (Atg) genes have been implicated in regulating the autophagic process [8].
The core Atg proteins are highly conserved and can be assembled into different complexes
such as the autophagy-initiating Atg1/Ulk protein kinase complex,  Beclin1-class III  PI3K
complex, the Atg5-Atg12 and Atg8/LC3 ubiquitin-like conjugation systems, and the Atg9
recycling system [8, 9].
Protein posttranslational modification (PTM) plays a pivotal role in increasing proteome
complexity and determining the fates of proteins [10–13]. It is a widespread mechanism that
involves the addition of a functional group covalently to a protein. The major types of PTMs
include phosphorylation, glycosylation, acetylation, ubiquitination, methylation, and
lipidation. The diversity of PTM provides enormous flexibility for control of protein
structure, localization, activity, and function; this modification can be reversible or irrever-
sible. Recent studies have identified various forms of PTMs in the regulation of autophagy
[14–16]. Some PTMs regulate autophagy by affecting the enzymatic activity of Atg proteins.
For example, the Ulk1 kinase (the key initiator of autophagy) can be phosphorylated by
upstream regulators such as AMP-activated protein kinase (AMPK) and mammalian target
of rapamycin (mTOR), which result in the activation or inactivation of Ulk1 kinase activity,
respectively [17–19]. Additionally, Ulk1 can also be acetylated at K162 and K606 by acetyl
transferase KAT5/TIP60, and the PTM acetylation is vital to the activation of Ulk1 [20]. PTMs
can also regulate autophagy by changing the interacting partners of Atg proteins [21, 22]. It
has been shown that the posttranslational modification of Beclin1 affects its interaction with
Vps34 complex. Zalckvar et al. showed that death-associated protein kinase (DAPk)-
mediated phosphorylation of Beclin1 promotes the association between Beclin1 and Vps34
complex [23]. On the contrary, Beclin1 phosphorylation by CDK1 leads to the dissociation
of Beclin1 from Vps34 [24].
Accumulating evidence indicates that protein ubiquitination and deubiquitination play
multiple roles in the regulation of protein stability and signaling during autophagy [15, 16].
Several ubiquitin E3 ligases and deubiquitinating enzymes (DUBs) have been shown to
regulate autophagy at different stages. However, the detailed mechanisms of the E3 ligases
and the DUBs in controlling both “on” and “off” signals of autophagy remain unclear. The
ubiquitin system is also essential for the recognition and removal of damaged organelles and
invading pathogens during selective autophagy processes. Moreover, two ubiquitin-like
conjugation systems are found to be crucial for the expansion of the elongation and expansion
of autophagosomal membrane. Here, we will discuss recent advances on the role of ubiquitin
systems in autophagy.
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2. Ubiquitin modification and protein fate determination
2.1. Ubiquitin modification
Ubiquitination is an ATP-dependent enzymatic process that involves the covalent conjugate a
highly conserved 8-kDa ubiquitin (Ub) peptide to lysine residues of target proteins [25]. The
ubiquitination reaction requires three classes of enzyme: ubiquitin-activating enzymes (E1),
ubiquitin-conjugating enzymes (E2), and substrate-specific ubiquitin ligases (E3) [25, 26]. In
mammals, there are more than 500 E3 ligases, 30 E2-conjugating enzymes, and two E1-
activating enzymes [26–28]. The E1 enzyme activates free ubiquitin by forming a thioester
linkage between the C-terminal carboxyl group of ubiquitin and the E1 cysteine sulfhydryl
group in an ATP-dependent manner. The activated ubiquitin is then transferred from E1 to the
catalytic cysteine of E2, which can determine the type of ubiquitin chain formed. Finally, the
E3 binds both the Ub-charged E2 and substrates to catalyze and transfers the C-terminus of
Ub to the lysine residue of substrates. The E3 ligase transfers ubiquitin to specific protein
targets and is critical for conferring the substrate specificity. Because of the large number of E2
and E3 enzymes, a broad range of substrates can be modified by distinct ubiquitin chain
configurations.
Ubiquitination of a substrate can be classified according to the number of ubiquitins, linkage
of ubiquitin chains, and chain length [27]. It has been shown that the attachment of an ubiquitin
molecule at one site in the substrate causes monoubiquitination [28, 29]. Whereas monoubi-
quitin is conjugated on several lysine residues of the substrate results in multiubiquitination.
Mono- and multiubiquitination regulate processes that range from histone modification to
membrane-receptor endocytic trafficking [30]. In addition, the E2/E3 complexes can catalyze
further cycles of ubiquitination on the substrate-conjugated ubiquitin, resulting in substrate
polyubiquitination [28, 29]. Ubiquitin links to another ubiquitin molecule to form polyubiqui-
tin chain via one of its seven lysines (K6, K11, K27, K29, K33, K48, and K63) or the N-terminal
methionine residue (M1) [27, 31]. The polyubiquitin chain can elongate using the same lysine
residue on each ubiquitin (homogeneous ubiquitin chain) or the polyubiquitin chain can form
through conjugation with mixed topology (heterogeneous ubiquitin chain). The different
ubiquitination modification patterns provide a way to increase the diversity of protein
regulation and functions. For example, the polyubiquitin chain linked through Lys48 (K48-
linked polyubiquitin) provides a signal for protein degradation by the 26S proteasome, thereby
regulating the stability of proteins [32]. The K11-linked polyubiquitin can trigger the degra-
dation of cell cycle regulators via the ubiquitin-proteasome pathway during mitosis [33, 34].
Moreover, ubiquitination modification also regulates protein-protein interaction, enzyme
activity, and the cellular localization of proteins. The K63-linked polyubiquitin was reported
to be involved in signal transduction [35], kinase activation [36, 37], and protein-protein
interaction [21]. Together, these findings indicate that ubiquitin modification affects diverse
cellular processes by regulating the stability and the function of proteins. The temporal and
spatial control of ubiquitin signaling plays a pivotal role to maintain normal cellular functions.
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2.2. Deubiquitinating enzymes (DUBs)
Protein ubiquitination is a reversible posttranslational modification process. The process to
cleave ubiquitin from proteins and other molecules is called deubiquitination, and the process
is catalyzed by a large group of ubiquitin-cleaving proteases, the deubiquitinating enzymes
(DUBs) [38–41]. DUBs can be classified into five families: ubiquitin-specific proteases (USPs),
ubiquitin C-terminal hydrolase (UCHs), ovarian tumor proteases (OTUs), Machado-Joseph
disease domain proteases (MJDs), and Jab1/Mpn/Mov34 metalloenzymes (JAMMs) and play
several critical roles in the ubiquitin pathway [38, 40]. First, they are responsible for processing
inactive ubiquitin precursors. The ubiquitin is translated in the form of linear polyubiquitin
chain or fusion with ribosomal proteins. DUBs are needed to generate free ubiquitin monomer.
Second, DUBs can antagonize E3 ligases by removing the ubiquitin molecule or trimming the
ubiquitin chain form substrates, thereby changing the ubiquitin signaling or stability of
targeted proteins. Finally, DUBs are required for the recycling of ubiquitin molecule. The
ubiquitin molecules cleaved from substrates or ubiquitin chains can re-enter to the free
ubiquitin pool. The coordination of E3 ligases and DUBs leads to conjugating, trimming, and
removing ubiquitin modification of target proteins for various biological processes.
3. The role of ubiquitin modifications in autophagy regulation
Recent investigations have implicated the involvement of complex signaling pathways during
different stages of autophagic process. Modifying autophagy-related proteins (Atg) by
posttranslational modification is one of the important mechanisms to control proper autopha-
Figure 1. Functional role of ubiquitin-related enzymes (E3 ligases and DUBs) in autophagy regulation. An overview
shows the involvement of the ubiquitination events during different steps of autophagy. Ubiquitination modifications
by E3 ligases are shown in red arrows, and deubiquitination by DUBs are shown in blue arrows. “+” indicates that
enzymes play positive regulatory roles (USP10, USP13, and USP19), and “−” indicates those thought to play negative
roles (SCFβTrCP, CUL5, CUL3/KLH20, A20, NEDD4, CUL4/DDB1, Parkin, and RNF5) in autophagy. TRAF6 can function
as positive or negative regulator in autophagy via ubiquitination modification of different substrates.
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gic activity [15, 16]. Many autophagy regulators are found to be substrates for ubiquitin E3
ligases or deubiquitinating enzymes (DUBs) [42, 43]. Ubiquitination modification of these
autophagy regulators controls autophagy induction, nucleation, maturation, or termination.
Here, we are going to review recent findings on the role of E3 ligases and DUBs in the regulation
of autophagy (Figure 1).
3.1. Ubiquitin systems and autophagy initiation
Many signaling pathways participate in the induction of autophagy. The inhibition of mTOR
function and the activation of Ulk1 complex are two major mechanisms in the initiation of
autophagy [8]. Several ubiquitination enzymes have been shown to participate in the induction
of autophagy by modifying the initiators of autophagy [44–47]. It has been reported that mTOR
inhibitor, DEPTOR, can be ubiquitinated by SCFβTrCP E3 ubiquitin ligase and CUL5, and led to
the degradation of DEPTOR. In response to growth signals, DEPTOR is phosphorylated by
the downstream components of mTOR pathway such as RSK1 and S6K1, and the phosphory-
lated DEPTOR is then targeted for ubiquitination by SCFβTrCP E3 ligase for degradation [44,
45]. Interestingly, Antonioli et al. recently showed that CUL5 can also catalyze the DEPTOR
ubiquitination and promote its degradation under normal conditions. The degradation of
DEPTOR leads to the activation of mTOR, which acts as an inhibitor of autophagy. Upon
autophagy stimulation, the CUL5-mediated degradation of DEPTOR is inhibited by Ambra1
in an Ulk1-dependent manner and promotes the onset of autophagy [46, 47].
The mTOR activity can also be regulated by ubiquitination through the TRAF6 E3 ligase [48].
Upon amino acids stimulation, TRAF6 is recruited to mTOR complex 1 (mTORC1) through
p62 and catalyzes K63-linked polyubiquitination of mTOR which is required for mTORC1
translocation to the lysosome and its subsequent activation. Moreover, TRAF6 has also been
shown to promote K63-linked polyubiquitination of Ulk1, which results in Ulk1 stabilization,
self-association, and autophagy induction [49]. The TRAF6-mediated Ulk1 ubiquitination
depends on Ambra1 which is also a substrate target of Ulk1 during autophagy induction. These
findings together indicate that ubiquitin system and ubiquitin-related enzymes play a critical
role in autophagy initiation.
3.2. Ubiquitin systems and autophagy nucleation
The Beclin1 and Vps34, a class III phosphoinositide 3-kinase (PI 3-kinase), are the key regula-
tors in the nucleation step of autophagy [8]. Beclin1 acts as an adaptor, which recruits cellular
components such as Ambra1 and UVRAG to form different Beclin1-Vps34 complexes that are
responsible for modulating the activity of Vps34. Recent studies have shown that the interac-
tion between Beclin1 and its binding partners can be regulated by PTMs including ubiquiti-
nation [21].
It was reported that, upon lipopolysaccharide (LPS) stimulation, TRAF6 catalyzes K63-linked
polyubiquitination of Beclin1 at K117 [50]. The TRAF6-mediated Beclin1 ubiquitination leads
to the disassociation of Beclin1 with Bcl2 and promotes autophagy. On the contrary, the
deubiquitinating enzyme A20 antagonized the TRAF6-mediated Beclin1 ubiquitination and
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abrogated autophagy induction. Recently, Chen et al. showed that the E3 ubiquitin ligase
Parkin, which is found to be involved in the neurodegenerative Parkinson’s disease (PD), can
also catalyze the monoubiquitination of Bcl2 [51]. Parkin-mediated Bcl2 ubiquitination
increases the steady-state levels of Bcl2 and enhances the interactions between Bcl2 and Beclin1,
leading to the inhibition of autophagy. Moreover, E3 ubiquitin ligase Nedd4 (neural precursor
cell expressed developmentally down-regulated protein 4) promotes Beclin1 degradation
through proteasomal system in the absence of Vps34 interaction [52]. Nedd4 controls the
stability of Beclin1 via K11-linked polyubiquitination. Through the degradation of Beclin1,
Nedd4 acts as a negative regulator of autophagy. Besides E3 ligases, Liu et al. showed that
USP10 and USP13 DUBs also participate in the autophagy nucleation by regulating the stability
of Beclin1-Vps34 complex components including Vps34, Beclein1, Vps15, and Atg14L [53].
Unexpectedly, Beclin1-Vps34 complex also promotes the stability and activity of USP10 and
USP13 [53, 54]. Recently, the deubiquitinating enzyme USP19 was found to stabilize Beclin1
by removing the K11-linked ubiquitin chains of Beclin-1 at lysine 437 and act as a positive
regulator of autophagy [55]. Moreover, USP19 inhibits RIG-I-mediated type I interferon (IFN)
signaling and antiviral immune responses by blocking RIG-I-MAVS interaction in a Beclin-1-
dependent manner. In addition, the deubiquitinating enzyme USP33 is also involved in
autophagy induction by deubiquitinating the RAS-like GTPase RALB under starvation
conditions [56]. RALB interacts with the exocyst components EXO84. Upon nutrient depriva-
tion, the USP33-mediated deubiquitylation of RALB induces the assembly of RALB-EXO84-
Beclin1 complex and the initiation of autophagy.
By interfering the interaction or by controlling the stability of the Vps34-Beclin1 complex
components, the ubiquitin system provides a flexible and diverse way to regulate autophagy
nucleation.
3.3. Ubiquitin systems and autophagosome elongation/expansion
The Atg8 (LC3 and GABARAP in mammals) and Atg12 ubiquitin-like conjugation systems are
two major pathways involved in the regulation of autophagosomal elongation and expansion
[57]. Similar to ubiquitination, Atg12 is conjugated to the lysine residue in Atg5 by the E1
enzyme Atg7 and the E2 enzyme Atg10. The Atg12-Atg5 conjugate subsequently forms a
complex with Atg16 for phagophore membrane elongation. On the other hand, Atg8 is first
processed at the C-terminus by the cysteine protease Atg4 and then activated by Atg7 (E1) and
Atg3 (E2) for the conjugation of the lipid phosphatidylethanolamine (PE). Atg4 is also required
for the cleavage of Atg8 from PE on the autophagic membrane after the completion of
autophagosome formation. As Atg4 plays a critical role in the phagophore expansion and
autophagosome completion, depletion of Atg4 inhibits the processing of Atg8 paralogues and
autophagy. It has been shown that the membrane-associated E3 ligase RNF5 regulates
autophagy by ubiquitinating Atg4b and promoting the proteolytic degradation of Atg4b [58].
3.4. Ubiquitin systems and autophagy termination
Like the initiation of autophagy, the termination of autophagy is also tightly regulated after
completion of each run. The failure of autophagy termination under prolonged starvation will
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lead to unrestrained cellular degradation and cell death [59]. In addition to mTOR activation
induced by the regeneration of intracellular nutrients, recent studies revealed that the protea-
somal degradation of autophagy components also plays a critical role in controlling autophagy
termination [46, 59]. It has been shown that CUL4 controls autophagy termination by promot-
ing Ambra1 ubiquitination and regulating Ambra1 protein levels [47]. Under high nutrient
conditions, DDB1/CUL4 mediates Ambra1 ubiquitination and maintains Ambra1 at low level.
Upon starvation, CUL4 dissociates with Ambra1, and Ambra1 is stabilized by Ulk1 phosphor-
ylation. The phosphorylated Ambra1 inhibits CUL5-mediated degradation of DEPTOR and
further downregulating mTOR activity. Under prolonged stress conditions, DDB1/CUL4 re-
establishes its interaction with Ambra1 and promotes the ubiquitination and degradation of
Amba1, which in turn leads to autophagy termination [46].
Recently, Liu et al. reported that CUL3 also participates in the termination of autophagy [59].
KLHL20/CUL3 recruited autophosphorylated Ulk1 for ubiquitination and degradation under
stress conditions. Moreover, KLHL20/CUL3 also promotes ubiquitination of phagophore-
residing VPS34 and Beclin1, and the ubiquitination leads to their degradation. KLHL20/CUL3
plays a crucial role in autophagy termination by regulating the turnover of Ulk1 and VPS34
complex to restrain the amplitude and duration of autophagy.
To date, many ubiquitination events have been shown to participate in autophagy regulation.
The ubiquitin-mediated modification functions at different steps of autophagy and targets at
different substrates in response to distinct stress stimulation. Moreover, some of the ubiquiti-
nation modifications are antagonized by the deubiquitinating enzymes. Therefore, the
ubiquitin system provides flexible, diverse, and effective ways to control the onset and the
termination of autophagy.
4. Ubiquitination modification and selective autophagy
Although autophagy was originally thought to be a non-selective pathway which appears to
randomly sequester cytosolic components for lysosomal degradation, it is now recognized that
autophagy also acts in selective processes that involves specific receptors to target certain
cargos [60, 61]. Accumulating evidence indicates that many intracellular degradation events
are processed through selective autophagy, including the turnover of damaged organelles such
as mitochondria (mitophagy) [62, 63] and peroxisomes (pexophagy) [64, 65], removal of protein
aggregates (aggrephagy) [66], and elimination of intracellular pathogens (xenophagy) [67,
68].
Upon the induction of selective autophagy, phagophore is enriched with specific cargos in a
process dependent on cargo receptors [61]. These cargo receptors can interact with both target
proteins and the autophagic vesicle components such as LC3/Atg8 family proteins, which
result in the enclosure of selective cargos to the autophagosome and promote the autophagic
degradation of cargos. Like nonselective autophagy, selective autophagy also plays an
important role in cellular homeostasis and has been associated with a variety of human
diseases [63, 69].
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4.1. The role of ubiquitin in selective autophagy
Ubiquitination has long been recognized as a key regulator to determine protein fate by tagging
proteins for proteasomal degradation [60]. Ubiquitination of cargo proteins plays a crucial role
in selective autophagy process. In selective autophagy, cargos are ubiquitinated and recog-
nized by ubiquitin-binding receptors to transport cargos for lysosomal degradation [70].
Therefore, ubiquitin acts as a degradation signal for selective autophagy. Protein aggregates,
damaged organelles, or pathogens can be tagged and targeted for degradation through the
lysosome machinery to maintain cellular homeostasis. In this section, we will illustrate the
mechanism and importance of ubiquitination in selective autophagy (Figure 2).
Recent studies have shown that selective autophagy is responsible for delivering a wide range
of cargos to the lysosome for degradation [70–72]; however, the detailed mechanisms of
selective degradation by lysosome remain largely unknown. Several types of adaptor proteins
such as p62, NDP52, optineurin (OPTN), NBR1, and HDAC6, which contain the ubiquitin-
binding motif, have been reported to target ubiquitinated cargos for lysosomal degradation
under stress conditions [70, 71]. Besides the ubiquitin-binding motif, these cargo receptors
often also contain a LC3-interacting region (LIR) or Atg8 interaction motif to interact with the
LC3/Atg8 family members [60, 70]. Therefore, through binding to ubiquitinated cargos and
LC3 simultaneously, these receptors can deliver selective cargos to the autophagosome and
promotes the autophagic degradation.
Figure 2. The involvement of ubiquitin-related enzymes (E3 ligases and DUBs) in selective autophagy. Selective au-
tophagy is a process that depends on the ubiquitin signals and the ubiquitin recognition adaptor proteins. (a) The E3
ligase (Parkin) promotes mitophagy by catalyzing the ubiquitination of mitochondrial proteins, and DUBs (USP15,
USP30, and USP35) inhibit mitophagy by removing the ubiquitin signals of mitochondrial proteins. USP8 participates
in mitophagy by removing non-canonical K6-linked ubiquitin chains from Parkin, a process required for the efficient
recruitment of Parkin to depolarized mitochondria. (b) USP36 removes the ubiquitin markers from protein aggregates,
which inhibits aggrephagy. (c) The DUB SseL which is secreted by Salmonella can remove the ubiquitin tags on Salmo-
nella-containing vacuole (SCV) and aggresome-like induced structures (ALIS) in order to escape xenophagy. “U”
means ubiquitin (this involves different types of ubiquitination); the red arrows and the blue arrows indicate ubiquiti-
nation events and deubiquitination events, respectively.
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Ubiquitinated cytosolic proteins can undergo degradation via proteasome or the lysosome.
Proteins conjugated with K48-linked polyubiquitin chains often are recognized by UBD
(ubiquitin-binding domain) containing proteasomal receptors and degraded by proteasome
[73]. On the other hand, the ubiquitin-binding autophagy adaptors have been shown to interact
with cargos containing K63-linked polyubiquitin chains [74–77]. Cargos modified with K63
polyubiquitination are preferentially targeted via the autophagy/lysosomal degradation
pathway.
4.2. E3 ligases and DUBs in selective autophagy
Given that ubiquitin plays a critical role by acting as a tag for substrates recognition in selective
autophagy, it is important to understand the regulatory mechanism of ubiquitin system during
this process. E3 ubiquitin ligases and deubiquitiylating enzymes (DUBs) involved in the cargos
ubiquitination are crucial in the selective autophagy regulation.
Autophagy of the mitochondria, also known as mitopahagy, depends on a set of ubiquitination
modification on mitochondrial outer membrane proteins [63]. Upon the induction of mitoph-
agy, Parkin, an E3 ubiquitin ligase that is also involved in the pathogenesis of Parkinson’s
disease, is recruited to the depolarized mitochondria [77, 78] to ubiquitinate several mito-
chondrial proteins, including MFN1, MFN2, VDAC1, and MIRO [79–81]. How is Parkin
recruited to the damaged mitochondria? Recently, three studies showed that Pink1-mediated
phosphorylation of ubiquitin at Ser65 activates Parkin [82–84]. The accumulation of ubiquiti-
nated mitochondrial proteins then recruits the autophagy adaptors NDP52 and optineurin,
which then promote the formation of mitophagy [85, 86]. Mitophagy is also modulated by a
number of DUBs. It has been shown that USP15 [87], USP30 [88, 89], and USP35 [89] reduce
the ubiquitin levels from the ubiquitinated mitochondrial proteins, thereby preventing the
recognition by autophagy adaptors and blocking mitophagy. Moreover, TRAF6 [90] and USP8
[91] can also participate in mitophagy by regulating the ubiquitination of Parkin.
The selective degradation of protein aggregates requires aggregative proteins to be labeled
with K63-linked ubiquitin chains which then are recognized by autophagy adaptors including
p62 and NBR1 and HDAC6 [92]. Taillebourg et al. recently showed that DUB USP36 can act as
a negative regulator to inhibit the selective autophagy of protein aggregates by removing the
ubiquitin signals [93]. However, the specific ubiquitin ligases involved in aggrephagy remain
to be identified.
The process of selective autophagy also plays a crucial role in host defense. It has been shown
that the intracellular pathogen Salmonella Typhimurium can be eliminated by selective
autophagy [94]. After infection, Salmonella Typhimurium grows in a membranous compart-
ment, the Salmonella-containing vacuole (SCV). The bacterial infection often induces immune
and nonimmune cells forming aggresome-like induced structures (ALIS). The host cell can
eliminate SCV and ALIS by ubiquitination and xenophagy. However, S. Typhimurium can
remove the ubiquitin signals by secreting the deubiquitinating enzyme SseL, which leads to
lower autophagy flux due to the failure of autophagy-receptor recognition [94].
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The ubiquitin-mediated selective autophagy plays an important role in maintaining cellular
homeostasis and in the elimination of invading pathogens. Therefore, it is critical to further
identify the E3 ubiquitin ligases and DUBs involved in selective autophagy under physiolog-
ical and pathological conditions.
5. Ubiquitin system and autophagy in human health and disease
Like the ubiquitin-proteasome system, autophagy is a tightly regulated lysosomal degradation
pathway which has been implicated in various human pathological and physiological
processes. Basal autophagy is essential for removing misfolded proteins and damaged
organelles; therefore, autophagy is also important for maintaining normal cellular processes
in all tissues [95, 96]. Since the ubiquitin system serves as a central regulator to modify the
autophagic activity and functions, it is no doubt that the protein modification by ubiquitination
and deubiquitination also play crucial roles in autophagy-related diseases [97–100]. However,
the relationship between the ubiquitin system and the autophagy-related pathological
processes remain unclear. In this section, we will discuss the recent findings and progresses in
the field.
5.1. Ubiquitin system and autophagy in cancer
Cancer is one of the first human diseases identified to be associated with autophagy malfunc-
tion [101]. Some autophagy genes mutation or deletion can lead to cancer. For instance,
monoallelic deletion of Beclin1 gene has been detected in 40–75% of human breast, ovarian,
and prostate cancer [102]. Besides Beclin1, many autophagy genes are found to be involved in
human cancer, including UVRAG [103], Atg5, and Atg7 [104]. Accumulating evidence has
indicated that autophagy also plays a crucial role in cancer cell progression. Autophagy likely
plays distinct roles during different stages of cancer development [105]. It has been shown that
autophagy has a preventive effect against tumorigenesis and the cancer occurrence during
early cancer formation. However, autophagy provides a protective mechanism and supports
the tumor growth once cancer progresses [105–107].
Although the role of autophagy in cancer progression remains elusive, several recent studies
have shown that the inhibition of autophagic pathway can enhance the efficacy of anticancer
drugs [108, 109]. Shao et al. showed that autophagy inhibitor-1 (spautin-1), an inhibitor of
USP10 and USP13, can enhance Imatinib mesylate (IM)-induced cell death in chronic myeloid
leukemia (CML) in a Beclin1-dependent manner [102]. Since autophagy plays a role in IM
resistance and spautin-1 inhibits IM-induced autophagy in CML cells, inhibition of autophagy
with the DUBs inhibitor spautin-1 may provide a promising approach to increase the efficacy
of IM for patients with CML [110]. In another study, Yang et al. showed that knockdown of the
regulator of CUL1 (ROC1) suppresses the growth of liver cancer cells through the induction
of autophagy and senescence [103]. The triggering of autophagic response in ROC1 silencing
cells is through the accumulation of the mTOR inhibitory protein DEPTOR [111]. Another link
of ubiquitination regulation in autophagy and cancers is that the ubiquitin modification of
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Beclin1 and p53 by E3 ligases or DUBs can balance the interaction between Beclin1 and p53,
and their interaction is thought to regulate the cellular decision between apoptosis and
autophagy in embryonal carcinoma cells [43].
As ubiquitination modification in autophagy regulation plays a notable role in cancer cells, it
is crucial to further investigate the detailed mechanisms of how ubiquitin system regulates
autophagic function during cancer progression. Findings from these studies will provide new
insights into cancer biology as well as novel approaches in cancer prevention and treatment.
5.2. Ubiquitin system and autophagy in neurodegenerative diseases
In recent years, there is increased attention on the role of autophagy in neurodegenerative
diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s
disease (HD) [112, 113]. These neurodegenerative disorders are usually characterized by the
presence of protein inclusions and aggregates in neurons, which result from the failure of
protein degradation, and these protein aggregates may be one cause of the progressive
degeneration and/or death of neuronal cells [113, 114]. The ubiquitin-proteasome and autoph-
agy-lysosome pathways are the two major pathways to degrade misfolded proteins and
damaged organelles [60]. Accumulating evidence indicates that the dysfunction of autophagy
may result in the accumulation of abnormally folded protein aggregates, which may contribute
to neurodegenerative disorders [112, 114]. Although there are growing studies indicating the
importance of autophagy in the neurodegenerative diseases, the molecular mechanisms of
how autophagy or selective autophagy functions in these disorders are still not completely
understood.
Ubiquitination of cellular proteins and organelles has been shown to promote the autophagic
clearance of cargos associated with neurodegenerative diseases [76, 112, 115]. Parkin is a
multifunctional ubiquitin ligase that has been found to be mutated in sporadic and familial
early onset Parkinson’s disease [116]. The involvement of Parkin and DUBs such as USP15,
USP30, and USP35 in mitophagy has also been demonstrated to be critical in neurodegenera-
tion related to PD [43, 116]. Besides its role in regulating mitochondrial homeostasis, it has
been shown that Parkin catalyzes the ubiquitination modification of misfolded proteins, which
then promotes the degradation of these substrates via proteasome or autophagy pathway
[116]. The dysfunction of Parkin leads to the accumulation of protein aggregates and causes
some neurodegenerative diseases. It was also reported that the C-terminus of Hsc70 interacting
protein (CHIP) E3 ubiquitin ligase can promote the ubiquitination of denatured proteins and
play an important role in neurodegeneration. By binding to different E2 enzymes, CHIP can
catalyze K48- and K63-linked polyubiquitin chains which promote proteins degradation via
chaperone-dependent ubiquitin-proteasome system and autophagy-lysosome pathway,
respectively [117].
5.3. Ubiquitin system and autophagy in infectious diseases
Activation of autophagy provides a promising approach in the treatment of infectious diseases.
Recent studies have shown that this cellular process can either selectively target microorgan-
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isms for lysosomal degradation (referred to as xenophagy) or promote the delivery of microbial
nucleic acids and antigens to endo/lysosomal compartments for innate and adaptive immunity
activation [118–120]. Accumulating evidence indicates that autophagy activity is higher upon
the pathogen infection [119], and it is also known that autophagy can facilitate the intracellular
antigen-processing events [118]. Moreover, the autophagy pathway can cross talk with
immunity pathways [50, 120]. Interestingly, several reports also indicate that autophagy may
provide a pathway for pathogens to escape from host defense and help them to invade host
tissues [97].
The role of autophagy in immunity has been further confirmed by the finding of the connec-
tions between autophagy and several immune diseases. For example, Atg16 mutations are
associated with increased risk of an inflammatory bowel disease, Crohn disease, which affects
the gastrointestinal tract from the mouth to the anus [98]. Moreover, several studies have linked
single-nucleotide polymorphisms (SNPs) in ATG5 to systemic lupus erythematosus (SLE)
susceptibility [119]. Ubiquitination regulation of autophagy regulators was also found to
participate in the infectious events. The ubiquitin E3 ligase TRAF6 has been shown to catalyze
the K63-linked polyubiquitination of Beclin1 upon LPS stimulation and is critical for TLR4-
triggered autophagy in macrophages [50]. And the deubiquitinating enzyme A20 antagonizes
TRAF6-mediated ubiquitination of Beclin1 and limits the induction of autophagy in response
to TLR signaling. The balanced activity of TRAF6 and A20 is required for the inflammatory
response [50]. Another indication that ubiquitination modification regulates inflammation
through autophagy involves the E3 ligase RNF216 (ring finger protein 216). RNF216 was
reported to inhibit autophagy in macrophages by catalyzing K48-linked polyubiquitination of
Beclin1, which induces the degradation of Beclin1 [121]. Manipulating RNF216 expression may
provide a therapeutic approach for treatment of inflammatory diseases. In addition, the
ubiquitination modification processes participated in xenophagy also plays important roles
for the bacterial infection. The DUB SseL regulates the ubiquitin modification of SCVs and
ALIS and is important for the removal of pathogens [115]. Kuang et al. showed that RNF5
promotes the ubiquitination and the degradation of Atg4b limits the basal levels of autophagy
and influences susceptibility to bacterial infection [58].
In addition to the diseases discussed earlier, there are also disorders related to autophagy
dysfunction, including developmental defect, muscle atrophy, heart diseases, liver disease,
and aging [95]. However, it remains unclear whether the ubiquitin system also plays a role in
these diseases.
6. Conclusion
Protein ubiquitination is considered as one of the most important reversible posttranslational
modifications and has been implicates in various cellular signaling processes. Increasing
evidence indicates that the ubiquitin system plays a pivotal role in the regulation of autophagy
pathway. Recent studies have explored and highlighted the important functions of ubiquitin
system in the pathogenesis of autophagy-related diseases such as tumorigenesis,
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neurodegeneration, and pathogen infection. Further investigations to identify novel E3 ligases
and DUBs involved in autophagy and to determine their underlying mechanisms will not only
contribute to our understanding on how autophagy is controlled by the ubiquitin system but
also provide a rationale for novel therapeutic interventions in autophagy-related diseases.
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